- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | VITA LIFE SCIENCES LIMITED: Notice of General Meeting/Proxy Form | - | ASX | ||
| Mi | VITA LIFE SCIENCES LIMITED: Update - Notification of buy-back - VLS | - | ASX | ||
| Di | VITA LIFE SCIENCES LIMITED: Update - Notification of buy-back - VLS | - | ASX | ||
| Mo | VITA LIFE SCIENCES LIMITED: Update - Notification of buy-back - VLS | - | ASX | ||
| 09.04. | VITA LIFE SCIENCES LIMITED: Update - Notification of buy-back - VLS | - | ASX | ||
| 07.04. | VITA LIFE SCIENCES LIMITED: Update - Notification of buy-back - VLS | - | ASX | ||
| 24.03. | VITA LIFE SCIENCES LIMITED: Appendix 4G Corporate Governance Statement | 1 | ASX | ||
| VITA LIFE SCIENCES Aktie jetzt für 0€ handeln | |||||
| 24.03. | VITA LIFE SCIENCES LIMITED: Annual Report to shareholders | 3 | ASX | ||
| 18.03. | VITA LIFE SCIENCES LIMITED: AGM Date and Closing Date for Directors' Nomination | - | ASX | ||
| 11.03. | VITA LIFE SCIENCES LIMITED: Notification of cessation of securities - VLS | - | ASX | ||
| 05.03. | VITA LIFE SCIENCES LIMITED: Update - Notification of buy-back - VLS | - | ASX | ||
| 04.03. | VITA LIFE SCIENCES LIMITED: Update - Notification of buy-back - VLS | - | ASX | ||
| 02.03. | VITA LIFE SCIENCES LIMITED: Update - Notification of buy-back - VLS | - | ASX | ||
| 02.03. | VITA LIFE SCIENCES LIMITED: Update - Notification of buy-back - VLS | - | ASX | ||
| 24.02. | VITA LIFE SCIENCES LIMITED: Change of Director's Interest Notice | 1 | ASX | ||
| 23.02. | VITA LIFE SCIENCES LIMITED: Dividend/Distribution - VLS | - | ASX | ||
| 23.02. | VITA LIFE SCIENCES LIMITED: Preliminary Final Report | - | ASX | ||
| 20.01. | VITA LIFE SCIENCES LIMITED: Notification of cessation of securities - VLS | - | ASX | ||
| 14.01. | VITA LIFE SCIENCES LIMITED: Update - Notification of buy-back - VLS | - | ASX | ||
| 14.01. | VITA LIFE SCIENCES LIMITED: Update - Notification of buy-back - VLS | - | ASX |
Seite:
1 2 3 Weiter >>
60 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| GREEN THUMB INDUSTRIES | 4,888 | -0,08 % | Green Thumb Industries Reports Fourth Quarter and Full Year 2024 Results | CHICAGO and VANCOUVER, British Columbia, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. ("Green Thumb" or the "Company") (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer... ► Artikel lesen | |
| INDIVA | 0,016 | -100,00 % | SNDL Inc.: SNDL Emerges as Canada's Leading Producer of Edibles with Indiva Acquisition | CALGARY, AB, Nov. 4, 2024 /CNW/ - SNDL Inc. (Nasdaq: SNDL) ("SNDL" or the "Company") announced today that, in the context of Indiva Limited's ("Indiva" and together... ► Artikel lesen | |
| ALNYLAM PHARMACEUTICALS | 203,30 | -1,41 % | XFRA DUL: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| CASSAVA SCIENCES | 1,292 | +1,65 % | Cassava Sciences Aktie: Leichte Erholung nach Talfahrt | Trotz aktueller Kurserholung verzeichnet Cassava Sciences dramatische Verluste. Analysten bleiben skeptisch angesichts schwacher Finanzkennzahlen. Die Cassava Sciences-Aktie zeigt heute ein kleines... ► Artikel lesen | |
| NEKTAR THERAPEUTICS | 0,576 | +2,67 % | Nektar Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results | SAN FRANCISCO, March 12, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the fourth quarter ended December 31, 2024.
Cash... ► Artikel lesen | |
| ADASTRA | 0,182 | 0,00 % | Adastra Holdings Ltd.: Adastra Holdings Announces New Director | Langley, British Columbia--(Newsfile Corp. - March 3, 2025) - Adastra Holdings Ltd. (CSE: XTRX) (FSE: D2EP) ("Adastra" or the "Company"), a leading cannabis processor and producer of two top Canadian... ► Artikel lesen | |
| ACADIA PHARMACEUTICALS | 12,810 | -1,23 % | ACADIA PHARMACEUTICALS INC - 8-K, Current Report | ||
| SELLAS LIFE SCIENCES | 1,180 | +3,51 % | SELLAS Life Sciences Group, Inc.: SELLAS Announces Positive Overall Survival in Cohort 3 from the Ongoing Phase 2 Trial of SLS009 in r/r AML | - 8.9 Months Median Overall Survival (mOS) in Patients with AML-Myelodysplasia-Related Changes (AML-MRC) and 8.8 mOS in All Relapsed or Refractory to Venetoclax-Based Regimens Patients; Surpassing... ► Artikel lesen | |
| CATALYST PHARMACEUTICALS | 19,805 | -0,10 % | Catalyst Pharmaceuticals, Inc.: Catalyst Pharmaceuticals Announces Health Canada's Acceptance of AGAMREE New Drug Submission with Priority Review for Sub-Licensee Kye Pharmaceuticals | CORAL GABLES, Fla., April 08, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing... ► Artikel lesen | |
| MOLECULE HOLDINGS | 0,001 | 0,00 % | Molecule Holdings Inc. Announces Issuance of Third Partial Revocation Order | ||
| NUMINUS WELLNESS | 0,027 | -100,00 % | XFRA LR23: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILNUMINUS WELLNESS... ► Artikel lesen | |
| ZELIRA THERAPEUTICS | 0,228 | 0,00 % | ZELIRA THERAPEUTICS LIMITED: Investor Presentation | ||
| OPUS GENETICS | 0,651 | -1,36 % | Craig-Hallum sets $6 target for Opus Genetics stock, rates it a Buy | ||
| SOLIGENIX | 2,090 | -0,48 % | SOLIGENIX, INC.: Positive Outcome in 75% of CTCL Patients Treated with HyBryte for 18 Weeks | Interim Results from FDA-Funded Study Reinforces HyBryte's Rapid Response and Strong Safety Profile PRINCETON, N.J., April 14, 2025 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix... ► Artikel lesen | |
| ANI PHARMACEUTICALS | 61,50 | +0,82 % | Deep Dive Into ANI Pharmaceuticals Stock: Analyst Perspectives (6 Ratings) |
VITA LIFE SCIENCES LIMITED gehört der Branche Pharma an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VITA LIFE SCIENCES LIMITED finden Sie auf Wallstreet Online.
